Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial introductions91
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?82
Alveolar macrophages: guardians of the alveolar lipid galaxy66
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease51
Genetic variation in apolipoprotein A-V in hypertriglyceridemia43
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism37
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review35
Genetic determinants of plasma lipids in Greenlanders31
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?27
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?21
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases20
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1920
Oxidized LDL receptors: a recent update20
Familial hypercholesterolemia in children and the importance of early treatment20
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances20
Exosomes and lipid metabolism in metabolic and cardiovascular disorders19
Implementation science and genetic testing for familial hypercholesterolemia19
Lipid metabolism during pregnancy: consequences for mother and child18
Editorial introductions18
Nutrition and its impact on cardiovascular disease16
Nonalcoholic fatty liver disease: an update16
The current state of apolipoprotein E in dyslipidemia15
A new SPRING in lipid metabolism15
Familial hypercholesterolemia in pregnancy14
Recent advances in understanding the spectrum of genetic determinants of lipoprotein(a) levels14
Genetic determinants of pancreatitis risk in hypertriglyceridemia14
The need for national and international registries of patients with elevated lipoprotein(a)13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
From clinical development to real-world outcomes with inclisiran13
Editorial introductions13
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?12
APOE and familial hypercholesterolemia12
Genetic insights from Greenland: when geography, history and genomics converge12
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion12
Evolving guidelines on lipoprotein(a)11
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets11
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?11
In the wake of the Scandinavian Simvastatin Survival Study trial10
Can small dense LDL cholesterol be estimated from the lipid profile?10
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
Editorial introductions10
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis10
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent10
Newborn screening for lipid disorders9
Distinct roles of size-defined HDL subpopulations in cardiovascular disease9
Cardiomyocytes, sphingolipids and cardio myotoxicity9
Altered cardiovascular risk pattern of LDL cholesterol in older adults8
Pregnancy, cardiovascular health, and microchimerism8
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review8
Clinical associations between exercise and lipoproteins8
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease8
Genetic testing for familial hypercholesterolemia8
0.048269033432007